RESUMO
BACKGROUND: Multiple Myeloma (MM) is a B-cell malignancy in which clonal plasma cells progressively expand within the bone marrow (BM) as effect of complex interactions with extracellular matrix and a number of microenvironmental cells. Among these, cancer-associated fibroblasts (CAF) mediate crucial reciprocal signals with MM cells and are associated to aggressive disease and poor prognosis. A large body of evidence emphasizes the role of the urokinase plasminogen activator (u-PA) and its receptor u-PAR in potentiating the invasion capacity of tumor plasma cells, but little is known about their role in the biology of MM CAF. In this study, we investigated the u-PA/u-PAR axis in MM-associated fibroblasts and explore additional mechanisms of tumor/stroma interplay in MM progression. METHODS: CAF were purified from total BM stromal fraction of 64 patients including monoclonal gammopathy of undetermined significance, asymptomatic and symptomatic MM, as well as MM in post-treatment remission. Flow cytometry, Real Time PCR and immunofluorescence were performed to investigate the u-PA/u-PAR system in relation to the level of activation of CAF at different stages of the disease. Moreover, proliferation and invasion assays coupled with silencing experiments were used to prove, at functional level, the function of u-PAR in CAF. RESULTS: We found higher activation level, along with increased expression of pro-invasive molecules, including u-PA, u-PAR and metalloproteinases, in CAF from patients with symptomatic MM compared to the others stages of the disease. Consistently, CAF from active MM as well as U266 cell line under the influence of medium conditioned by active MM CAF, display higher proliferative rate and invasion potential, which were significantly restrained by u-PAR gene expression inhibition. CONCLUSIONS: Our data suggest that the stimulation of u-PA/u-PAR system contributes to the activated phenotype and function of CAF during MM progression, providing a biological rationale for future targeted therapies against MM.
Assuntos
Fibroblastos Associados a Câncer/citologia , Proteínas de Membrana/metabolismo , Mieloma Múltiplo/patologia , Receptores de Ativador de Plasminogênio Tipo Uroquinase/metabolismo , Regulação para Cima , Ativador de Plasminogênio Tipo Uroquinase/metabolismo , Idoso , Fibroblastos Associados a Câncer/metabolismo , Fibroblastos Associados a Câncer/patologia , Movimento Celular , Proliferação de Células , Progressão da Doença , Feminino , Regulação Neoplásica da Expressão Gênica , Humanos , Masculino , Metaloproteinases da Matriz/metabolismo , Mieloma Múltiplo/metabolismo , Estadiamento de Neoplasias , Células Tumorais CultivadasRESUMO
The prognosis of patients with human papillomavirus (HPV)negative cervical cancer is significantly worse than that of patients with HPVpositive cervical cancer. Understanding the mechanisms of this is crucial for preventing disease evolution. In the present study, the GV367snail family transcriptional repressor 2 (SNAI2) lentiviral vector was constructed and transduced into C33A cells. Subsequently, the proliferation of tumor cells was detected using the Cell Counting Kit (CCK)8 method. Flow cytometry was used to analyze the cell cycle progression of tumor cells. The glucose consumption of tumor cells was detected using an oxidase assay, and the senescence of tumor cells was detected using betagalactosidase staining. The gene expression and the activity of p38 and ERK1/2 were detected using reverse transcriptionquantitative PCR and western blotting, respectively. The C33ASNAI2 cell line was successfully established. Compared with HeLa and C33AWild cells, the proliferation and percentage of G0/G1phase cells in the C33ASNAI2 group were decreased, as detected by the CCK8 assay (100±0 vs. 239.1±58.3 vs. 39.7±20.1, P<0.01) and flow cytometry (34.0±7.1% vs. 46.2±10.6% vs. 61.3±5.3%, P<0.05). Compared with the HeLa group, the glucose consumption of the C33AWild and C33ASNAI2 groups was significantly decreased (P<0.01). The results of betagalactosidase staining showed that the proportion of betagalactosidasepositive cells in the C33ASNAI2 group was significantly decreased compared with the C33AWild group (P<0.01). Upregulation of SNAI2 enhanced the increase in p21 expression, and the decrease in CDK1, urokinase plasminogen activator receptor (uPAR) and cyclin D1 expression in C33A cells compared with C33AWild cells (P<0.05). In addition, the activities of p38, ERK1/2 and the phosphorylated (p)ERK1/2/pp38 ratio were decreased in the C33ASNAI2 group compared with the C33AWild and HeLa groups (P<0.05). In conclusion, SNAI2 enhanced HPVnegative cervical cancer C33A cell dormancy, which was characterized by G0/G1 arrest, by the downregulation of uPAR expression, and a decrease in the activity of the pERK1/2 and pp38MAPK signaling pathways in vitro. Cancer recurrence and metastases are responsible for most cancerrelated deaths. Given that SNAI2 is required for enhancing HPVnegative cervical cancer cell dormancy, regulating this process may promote cervical tumor cells to enter a continuous dormant state, which could be a potential approach for tumor therapy.
Assuntos
Proliferação de Células , Regulação Neoplásica da Expressão Gênica , Fatores de Transcrição da Família Snail , Neoplasias do Colo do Útero , Humanos , Neoplasias do Colo do Útero/patologia , Neoplasias do Colo do Útero/genética , Neoplasias do Colo do Útero/virologia , Neoplasias do Colo do Útero/metabolismo , Feminino , Fatores de Transcrição da Família Snail/metabolismo , Fatores de Transcrição da Família Snail/genética , Sistema de Sinalização das MAP Quinases , Células HeLa , Receptores de Ativador de Plasminogênio Tipo Uroquinase/genética , Receptores de Ativador de Plasminogênio Tipo Uroquinase/metabolismo , Linhagem Celular Tumoral , Papillomaviridae/genética , Senescência Celular , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo , Ciclo CelularRESUMO
Objective: To observe the inhibiting effects of an antisense u-PAR vector on invasion by highly invasive PC-3M cell subclones. Methods: The effects of an antisense vector on invasion by highly invasive PC-3M cell subclones were observed and compared in vitro by monolayer invasion assay and soft agar clone. Then, both a quantitative RT-PCR and zymography were used to exam the effects of the antisense u-PAR on activity of MMP-9 in those highly invasive cell subclones. Furthermore, the tumorigenesis rate and invasions by the cell subclones with or without the antisense u-PAR were observed in nude mice. Results: It is found that the speed of growth in vitro was slowing down by highly invasive PC-3M cell subclones transfected with the antisense u-PAR, and the ability of anchorage-independent growth of those cell subclones was also decreasing sharply,and the inhibiting rate was 79% and 60%, respectively. Although the antisense u-PAR didn′t change MMP-9 gene transcription, but they could inhibit the activation of MMP-9 of highly invasive PC-3M cell subclones. Moreover, the tumorigenesis rate of the cell subclones with the antisense u-PAR decreased and the growth of a neoplasm also slowed down. The t tests showed the difference between experimental and control groups reached statistical significance ( P